Navigation Links
Luxembourg joins EMBL

Today, the European Molecular Biology Laboratory [EMBL] announces Luxembourg as the new member of its international community. Accepted by EMBL's council and ratified by the parliament of Luxembourg, the Grand-Duchy has officially joined the institute as the 20th member state.

"EMBL is a key player in European molecular biology," says Franois Biltgen, Minister of Culture, Higher Education and Research, Luxembourg, "being part of its international network will provide a boost for Luxembourg's research in the growing field of molecular biology and will integrate its researchers even better into the European scientific community. In return Luxembourg will contribute to EMBL's various activities bringing in complementary strengths and technical expertise."

Through its membership Luxembourg will contribute to EMBL's pursuit of its five missions: to perform basic research in molecular biology; to train scientists, students and visitors at all levels; to offer vital services to scientists in the member states; to develop new instruments and methods in the life sciences and to actively engage in technology transfer activities. As a member state Luxembourg will benefit from the various services and training programmes that EMBL offers for its member states and it will have access to the research facilities at the five EMBL stations in Heidelberg and Hamburg, Germany, Grenoble, France, Hinxton, UK, and Monterotondo, Italy.

The delegate representing Luxembourg in EMBL's council will be Josiane Entringer of the Department for Research and Innovation of the Ministry for Culture, Higher Education and Research.

Luxembourg's activities in the molecular life sciences range from basic research in genetics, molecular biology and biomedicine to more applied areas such as cancer research and the development of health technologies. Since the foundation of its University in 2003, Luxembourg has actively contributed to education and training of Europe's scientific elite.

"We are very pleased to welcome Luxembourg as our new member state," says Iain Mattaj, Director General of EMBL, "Luxembourg has substantially contributed to the progress of research in the life sciences in the past years. Its overlapping research interests and its complementary expertise make it a very valuable addition to EMBL."


Contact: Anna-Lynn Wegener
European Molecular Biology Laboratory

Related biology news :

1. Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
2. Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
Post Your Comments:
(Date:9/29/2015)... -- News facts: , ... , Minimized design shrinks PC footprint , ... embedded Fujitsu PalmSecure authentication enable enterprises to realize benefits ... that good things come in small packages, with the ... desktop and mobile portfolio. Featuring workplace design that favors ...
(Date:9/28/2015)... YORK , Sept. 28, 2015  The ... respiration rate and body temperature, is an essential ... can be indicators of deterioration in a patient,s ... hospital, vital signs are typically taken during routine ... hours. If a patient deteriorates between these observation ...
(Date:9/28/2015)... Synaptics Inc. (NASDAQ: SYNA ), the ... Lenovo has selected Synaptics , Natural ID ™ ... smartphone, the Vibe P1. The new Vibe P1 ... and provide swift access to applications and mobile payments ... FS4202 sensor solution utilizes AES256-bit encryption of the fingerprint ...
Breaking Biology News(10 mins):
(Date:10/13/2015)... the United States , ... represents about 14% of all new cases of kidney cancer.   ... Canada and Europe .  PRCC represents ... --> Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) today announces ... AB (publ) ("AstraZeneca") have completed enrolment in a global Phase II ...
(Date:10/12/2015)... 2015  MiMedx Group, Inc. (NASDAQ: MDXG ), ... and patent-protected processes to develop and market advanced products ... Sports Medicine, Ophthalmic, and the Dental sectors of healthcare, ... filed against the Company has been dismissed by the ... and CEO, stated, "As we suspected, this case was ...
(Date:10/12/2015)... 12, 2015 cell surface marker detection ... 2022, according to a new report by Grand View Research, ... in incidence of oncology diseases and other cell-associated disorders. ... to reach USD 6.49 billion by 2022, according to a ... demand can be attributed to rise in incidence of oncology ...
(Date:10/12/2015)... DIEGO , Oct. 12, 2015  Patara ... debilitating allergic and inflammatory diseases and conditions, today ... A preferred stock financing. Concurrent with the close ... entered into a Loan and Security Agreement with ... up to $7 million. Patara will use the ...
Breaking Biology Technology: